Historial del iniciado Otro Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the complete record of transactions filed by Maya Martinez-Davis. Officer active across 1 company, notably GSK plc. Cumulatively, 32 filings have been logged. History available since 9 February 2026. The latest transaction was disclosed on 20 August 2026 (Sale). Regulator: RNS (LSE). The full history is accessible without signup.
Companies and markets linked to Maya Martinez-Davis Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 32 en total
● President, US · Directivos · 20 ago 2026 · GSK plc 3916 títulos @ 0,5215 GBP New York Stock Exchange (XNYS)ISIN ISIN US37733W2044FCA-NSM:960dc079-2d29-45dc-ae26-4620c41ddfc4-0 ● President, US · Directivos · 21 ago 2026 · GSK plc 40.481 títulos @ 0,5216 GBP New York Stock Exchange (XNYS)ISIN ISIN US37733W2044FCA-NSM:960dc079-2d29-45dc-ae26-4620c41ddfc4-1 ● President, US · Directivos · 14 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9673287-1 ● President, US · Directivos · 10 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9673287-3 ● President, US · Directivos · 10 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-3 ● President, US · Directivos · 14 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-1 ● President, US · Directivos · 7 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9661747 ● President, US · Directivos · 7 jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:289d903e-7ee1-4fa9-bcbd-3a43dc019bc2 ● President, US · Directivos · 22 jun 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9635096 ● President, US · Directivos · 22 jun 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:f96aec1d-517b-42fe-998e-999eab24c64e ● President, US · Directivos · 8 jun 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9612073 ● President, US · Directivos · 8 jun 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:c5a93bfc-97ef-49a5-bcc4-05857b3c3b90 ● President, US · Directivos · 22 may 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9588311 ● President, US · Directivos · 22 may 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:75c0e8d5-7c01-408c-a26c-84c6611b8f73 ● President, US · Directivos · 15 may 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9576175-2 ● President, US · Directivos · 15 may 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:0c2b3473-feab-43c0-81c0-8a4af4e4f91f-2 ● President, US · Directivos · 7 may 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:2a6a278d-267e-49ac-b714-020088a48904 ● President, US · Directivos · 22 abr 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:d5dec057-3334-4101-a527-1f9a20145e3c ● President, US · Directivos · 14 abr 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-18 ● President, US · Directivos · 14 abr 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-19 ● President, US · Directivos · 7 abr 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:e48c2f19-f550-4e43-bacf-e5379f6d6b51 ● President, US · Directivos · 23 mar 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:0a1152a8-d690-40e8-bef2-2b869d712c3f ● President, US · Directivos · 13 mar 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:a9ad7e9f-8439-4151-8c1a-69008fbc3c27 ● President, US · Directivos · 9 mar 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-9 ● President, US · Directivos · 20 feb 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5828e747-31e9-4d32-b844-dd5ef59cb57b 25 de 32 declaraciones
Ver más (7 restantes) About Maya Martinez-Davis Maya Martinez-Davis is a declarant linked to GSK plc, where she is President, US. Across 30 filings in total, the 30 sampled filings run from 2026-02-11 to 2026-07-17, with EUR 0 of purchases and EUR 1896 of sales in this recent sample.